{"nct_id":"NCT05953584","title":"A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2023-06-20","start_date_type":"ACTUAL","primary_completion_date":"2027-09-20","primary_completion_date_type":"ESTIMATED","completion_date":"2027-09-20","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["NVO"]}